It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 have found large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance.
blog.frontiersin.org...
Upon further scrutiny by our Research Integrity team about the objectivity of this paper during the provisional acceptance phase, it was revealed that the article made a series of strong, unsupported claims based on studies with insufficient statistical significance, and at times, without the use of control groups. Further, the authors promoted their own specific ivermectin-based treatment which is inappropriate for a review article and against our editorial policies.
Apparently the authors didn't follow through because someone else accepted it.
We note that last week the authors offered a revised version of their paper for consideration, based on the concerns discussed with the Handling Editor.
It is from American Journal of Therapeutics. PubMed, is a "library." You can find it in other libraries as well.
This is from the NIH
Ivermectin is the only difference between those countries?